Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Perixis 0.5mg capsules
0802020T0BIAAAF
|
Perixis | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Perixis 1mg capsules
0802020T0BIABAB
|
Perixis | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Perixis 5mg capsules
0802020T0BIACAA
|
Perixis | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Perjeta 420mg/14ml concentrate for inf vials
0801050BKBBAAAA
|
Perjeta | Pertuzumab | Malignant Disease and Immunosuppression | No data available |
|
Pertuzumab 420mg/14ml solution for infusion vials
0801050BKAAAAAA
|
Pertuzumab | Pertuzumab | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin 10mg/5ml solution for injection Cytosafe vials
0801020N0BBADAD
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin 200mg/100ml inf Cytosafe vials
0801020N0BBAFAF
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin 50mg/25ml inj Cytosafe vials
0801020N0BBAEAE
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin Rapid Dissolution 10mg inj vials
0801020N0BBAAAA
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin Rapid Dissolution 20mg inj vials
0801020N0BBABAB
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin Rapid Dissolution 50mg inj vials
0801020N0BBACAC
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Phelinun 50mg pdr and solvent for concentrate for inf vials
0801010S0BCAAAD
|
Phelinun | Melphalan | Malignant Disease and Immunosuppression | No data available |
|
Photofrin 15mg powder for solution for injection vials
0801050AHBBAAAA
|
Photofrin | Porfimer sodium | Malignant Disease and Immunosuppression | No data available |
|
Photofrin 75mg powder for solution for injection vials
0801050AHBBABAB
|
Photofrin | Porfimer sodium | Malignant Disease and Immunosuppression | No data available |
|
Pipobroman 25mg tablets
0801050BHAAAAAA
|
Pipobroman | Pipobroman | Malignant Disease and Immunosuppression | No data available |
|
Pirtobrutinib 100mg tablets
0801050CYAAAAAA
|
Pirtobrutinib | Pirtobrutinib | Malignant Disease and Immunosuppression | No data available |
|
Pirtobrutinib 50mg tablets
0801050CYAAABAB
|
Pirtobrutinib | Pirtobrutinib | Malignant Disease and Immunosuppression | No data available |
|
Plegridy 125micrograms/0.5ml inj pre-filled pens
0802040APBBABAB
|
Plegridy | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
Plegridy 63mcg/0.5ml and 94mcg/0.5ml inj pf pens TIP
0802040APBBAAAA
|
Plegridy | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
Pomalidomide 1mg capsules
0802040AJAAAAAA
|
Pomalidomide | Pomalidomide | Malignant Disease and Immunosuppression | No data available |
|
Pomalidomide 2mg capsules
0802040AJAAABAB
|
Pomalidomide | Pomalidomide | Malignant Disease and Immunosuppression | No data available |
|
Pomalidomide 3mg capsules
0802040AJAAACAC
|
Pomalidomide | Pomalidomide | Malignant Disease and Immunosuppression | No data available |
|
Pomalidomide 4mg capsules
0802040AJAAADAD
|
Pomalidomide | Pomalidomide | Malignant Disease and Immunosuppression | No data available |
|
Ponatinib 15mg tablets
0801050BQAAAAAA
|
Ponatinib | Ponatinib | Malignant Disease and Immunosuppression | No data available |
|
Ponatinib 30mg tablets
0801050BQAAACAC
|
Ponatinib | Ponatinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.